Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines

Planta Medica

Volumn 68, Issue 11, 2002, Pages 975-979

  Ho, Chi Kuan ^a   Huang, Yu Ling ^b   Chen, Chieh Chih ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Chemotherapy; Garcinia mangostana; Garcinone E; Guttiferae; Hepatocellular carcinoma; Xanthones

Indexed keywords

CISPLATIN; FLUOROURACIL; GARCINONE E; METHOTREXATE; MITOXANTRONE; PACLITAXEL; UNCLASSIFIED DRUG; VINCRISTINE; XANTHONE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; FRUIT; GARCINIA MANGOSTANA; HUMAN; HUMAN CELL; LD 50; LIVER CELL CARCINOMA; PARTITION CHROMATOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; FRUIT; GARCINIA MANGOSTANA; HUMANS; LIVER NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; TUMOR CELLS, CULTURED; XANTHENES;

CLUSIACEAE; GARCINIA; GARCINIA MANGOSTANA;

EID: 0036863655     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35668     Document Type: Article

References (21)

1. Govindachari TR, Kalyanaraman PS, Muthukumaraswamy N. Xanthones of Garcinia mangostana Linn. Tetrahedron 1971; 27: 3919-26
2. Goncalves DE, Oliverira W, Gottlieb OR, Lins Mesquita AA. Xanthones from Tovomita macrophylla. Phytochemistry 1972; 11: 3323-5
3. Chanarat P, Chanarat N, Fujihara M, Nagumo T. Immunopharmacological activity of polysaccharide from the pericarb of mangosteen garcinia: Phagocytic intracellular killing activities. J Med Asso Thail 1997; 80: S149-54
4. Gopalakrishnan C, Shankaranarayanan D, Kameswaran L, Nazimudeen SK. Effect of mangostin, a xanthone from Garcinia mangostana Linn. in immunopathological & Inflammatory reactions. Indian J Exper Biol 1980; 18: 843-6
5. Iinuma M, Tosa H, Tanaka T, Asai F, Kobsyashi Y, Shimano R, Miyauchi KI. Antibacterial activity of xanthones from Guttiferaeous plants against methicillin-resistant Staphylococcus aureus. J Pharm Pharmacol 1996; 48: 861-5
6. Shankaranarayan D, Gopalakrishnan C, Kameswaran L. Pharmacological profile of mangostin and its derivatives. Arch Internat Pharmaco Therapie 1979; 239: 257-69
7. Edenharder R, Tang X. Inhibition of the mutagenicity of 2-nitrofluorene, 3-nitrofluranthene and 1-nitropyrene by flavonoids, coumarians, quinones and other phenolic compounds. Food and Chem Toxicol 1997; 35: 357-72
8. Liou SS, Sheih WL, Cheng TH, Won SJ, Lin CN. γ-Pyrone compounds as potential anti-cancer drugs. J Pharm Pharmaco 1993; 45: 791-4
9. Lin CN, Liou SJ, Lee TH, Chuang YC, Won SJ. Xanthone derivatives as potential anti-cancer drugs. J Pharm Pharmacol 1996; 48: 539-44
10. Lin JH, Tong MJ, Stevenson D. A new human hepatocellular carcinoma cell line secreting hepatitis B surface antigen and alpha-fetoprotein. In: GN Vyas, JL Dienstag, JH Hoofragle (eds). Viral Hepatitis and Liver Disease Orlando: Grune & Atralton (abstr), 1984, p. 67
11. Chang C, Lin O, Lee TW, Chou CK, Lee TS, Liu TJ, P'eng FK, Chen TY, Hu CP. Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol 1983; 2: 1133-9
12. Taki T, Ishikawa H, Imai K, Yachi A, Matsumoto M. Immunological analysis of glycolipids on cell surfaces of cultured human tumor cell lines: Expression of lactoneotetrasylcaramide on tumor cell surfaces. J Biochem 1985; 98: 887-95
13. Baba M, Hasegawa H, Nakayaba M, Shimiza N, Suzuki S, Kamada N, Tani K. Establishment and characterization of a gastric cancer cell line (HUGC-00HIRA) producing high levels of G-CSF, GM-CSF and IL-6: The presence of autocrine growth control by G-CSE Am J Hematol 1995; 49: 207-15
14. Huang YL, Chen CC, Chen YJ, Huang RL, Shieh BJ. Three Xanthones and Benzophenone from Garcinia mangostana. J Nat Prod 2001; 64: 903-6
15. Mosmann T. A rapid colorimetric assay for cellular growth and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
16. Majumder PL, Sen RC. Moscatilin, a bibenzyl derivative from the orchid Dendrobium moscatum. Phytochemistry 1987; 26: 2121-5
17. Sakai SI, Katsura M, Takayama H, Aimi N, Chokethaworn N, Surttajit M. The structure of garcinone. Chem Pharm Bull 1993; 41: 958-60
18. Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K. Prognosis of primary hepatocellular carcinoma. Hepatology 1984; 4: 3S-6S
19. Carr BI. Escalating cisplatin doses by hepatic artery infusion (HAI) for advanced stage hepatocellular carcinoma (HCC). Carr BI. Sixth International Congress on Anti-Cancer Treatment, 1996, p. 367
20. Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: Current status and future directions. Cancer Treat Rev 1988; 15: 1-31
21. Lee Y-TN. Systemic and regional treatment of primary carcinoma of the liver. Cancer Treat Rev 1977; 4: 195-212